Novel Oral Anticoagulant Use Among Patients with Atrial Fibrillation Hospitalized with Ischemic Stroke or Transient Ischemic Attack

BACKGROUND: Novel oral anticoagulants (NOACs) have been shown to be at least as good as warfarin for preventing stroke or transient ischemic attack (TIA) in patients with atrial fibrillation (AF), yet diffusion of these therapies and patterns of use among AF patients with ischemic stroke and TIA hav...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Circ Cardiovasc Qual Outcomes
Autores principales: Patel, Priyesh A., Zhao, Xin, Fonarow, Gregg C., Lytle, Barbara L., Smith, Eric E., Xian, Ying, Bhatt, Deepak L., Peterson, Eric D., Schwamm, Lee H., Hernandez, Adrian F.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4512906/
https://ncbi.nlm.nih.gov/pubmed/26058721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.114.000907
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares